Igalmi (Dexmedetomidine) Sublingual Film To Transform Acute Agitation & Aggression ...
The Business Research Company's Igalmi (Dexmedetomidine) Sublingual film to Transform Acute Agitation & Aggression Treatment Market in 2025 LONDON, GREATER LONDON, UNITED KINGDOM, January 31, 2025 ...
来自MSN13 小时
What Is Allergy Immunotherapy, and Does It Work?
Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...
MarketBeat on MSN13 小时
Is Tonix Pharmaceuticals the Next Biotech Breakout?
Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...
H.C. Wainwright Remains a Buy on Bioxcel Therapeutics (BTAI)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Bioxcel Therapeutics (BTAI – Research Report) yesterday and set a price target ...
The Pharma Letter19 小时
First-in-class treatment approved by NICE for allergic rhinitis
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...
ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK ...
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ...